Are you interested in studying the T cell-mediated immune response to skin cancer? We have openings for post-docs and research professionals. Come join our team! https://t.co/mGMYiTJjId @AnngelaAdams@AnneMMacy@ES_Borden@lrnherrmann@uazmedphx
Introducing Dr. Adams. So proud of @AnngelaAdams who developed the first solar UV induced transplantable model of cSCC and used it to determine features of tumor rejecting neoantigens. Manuscript coming soon. Many thanks to @TMHalePhD@EmmanuelKatsani Dr Dickinson #dermtwitter
Hastings lab is at #SITC23! Come see @ES_Borden poster on neoantigen landscape in human cSCC tonight (137) and @AnngelaAdams poster on neoantigen-specific CD8 T cell constraint of cSCC tomorrow (136)
Karen T. Hastings, MD, PhD, has been named the inaugural chair of the University of Arizona College of Medicine - Phoenix Department of Dermatology.
Read about her journey here: https://t.co/HlixSrPlAq
#uazmedphx#dermatology#research#medicalschool
Dr. Karen Hastings, a professor of immunology and dermatology at the college, spoke with @cronkitenews about Phoenix receiving a poor skin health rating in one study and gave recommendations to decrease skin cancer risk.
Read here: https://t.co/Q5IcHXDLcC
Anngela Adams, an MD/PhD candidate at the college, received a prestigious F30 fellowship training grant from the National Cancer Institute to further her skin cancer research.
Read more here: https://t.co/hp66O2p3uT
Check out our review of MHCII on non-professional APCs in tumor microenvironment @AnneMMacy@lrnherrmann@AnngelaAdams
We have open position for post-doc, grad student or res tech/prof to study MHCII on tumor cells
AddThis | Home https://t.co/kHoUmJJLZF
Hear from two T32 Integrative Cancer Scholars, including @AnngelaAdams, in person @UAZCancer or via zoom 3/17 4pm Arizona time
Register here: https://t.co/pTyIZUBGQk
@AnngelaAdams is on 🔥. F30 NOA and oral presentation at an upcoming international meeting. Superstar grad students also have amazing mentors. Well done @KTHastingsMDPhD. @uazmedphx
@AnngelaAdams will be presenting in the adaptive and auto-immunity concurrent symposium at #ISID2023Tokyo. Come learn about her work on the T cell response to neoantigens in cutaneous squamous cell carcinoma using the mouse model that she created. We look to connecting with you.